title: Lack of clinically significant interference by spironolactone with the AxSym Digoxin II assay.
authors.affiliation: Department of Clinical Pharmacology, Christchurch Hospital, New Zealand.
authors.forename: Grant
authors.initials: G
authors.lastname: Howard
authors.forename: Murray
authors.initials: M
authors.lastname: Barclay
authors.forename: Chris
authors.initials: C
authors.lastname: Florkowski
authors.forename: Grant
authors.initials: G
authors.lastname: Moore
authors.forename: Anne
authors.initials: A
authors.lastname: Roche
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D016001:Confidence Intervals; D004077:Digoxin / Q000097:blood*; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods* / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D013148:Spironolactone / Q000097:blood*
chemical_list: D013148:Spironolactone; D004077:Digoxin